Clinical Trials
3 trialsNCT06110208 2025-02-26
Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase EARLY_PHASE1 Terminated
NCT03224819 2023-09-01
Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)
Amgen
Phase EARLY_PHASE1 Terminated
NCT02623582 2017-10-17
CD123 Redirected Autologous T Cells for AML
University of Pennsylvania
Phase EARLY_PHASE1 Terminated